Treatments
Featured Article
Treating Acute Urinary Tract Infection in Postmenopausal Women
Expert perspective on management and treatment of acute urinary tract infections in postmenopausal women.
Latest News
Relapse-Free Cure From MDR-TB Higher Than Anticipated
The frequency of relapse-free cure from multidrug-resistant tuberculosis is higher than previously anticipated.
Similar Safety and Efficacy for Rifampin vs Isoniazid in Children, Adolescents
For children younger than 18 years, 4 months of rifampin to treat latent Mycobacterium tuberculosis had similar rates of safety and efficacy and higher rates of adherence compared with 9 months of isoniazid.
AHA Issues Scientific Statement on Managing Chagas Cardiomyopathy
The most common findings in patients with Chagas cardiomyopathy include cardiac rhythm abnormalities, myocardial abnormalities, aneurysms, and thromboembolism.
Is Short-Course Antibiotic Treatment for CAP Effective?
To investigate what impact antibiotic treatment duration has on CAP outcomes, researchers from the Warren Alpert Medical School of Brown University conducted a search of various databases for studies comparing the safety and efficacy of treatment regimens lasting ≤6 days (short) and ≥7 days (long).
FDA Strengthens Warnings for Fluoroquinolone Antibiotics
The labeling changes are based on a review of postmarketing adverse event reports found in the FDA Adverse Event Reporting System (FAERS) database and published medical literature.
FDA Approves Plazomicin for Complicated Urinary Tract Infections
Zemdri carries a Boxed Warning describing reports of nephrotoxicity, ototoxicity, and neuromuscular blockade, as well as fetal harm if administered during pregnancy.
Potential Significant Toxicity With Methotrexate, Trimethoprim-Sulfamethoxazole Combination
The case involved a 68-year-old female patient with rheumatoid arthritis on methotrexate 10mg weekly who presented to the emergency department with complaints of lethargy and weakness after being prescribed a 2-week course of TS for a bacterial skin infection.
FDA Approves New Treatment for Onchocerciasis
Moxidectin, a macrocyclic lactone, is an anthelmintic drug that selectively binds to the parasite's glutamate-gated chloride ion channels.
FDA Grant Orphan Drug Status to Brincidofovir for Smallpox
Brincidofovir is the Company's lead candidate, a nucleotide analog that has antiviral activity against variola virus, which causes smallpox.
Treatment for Prosthetic Joint Infections Gets FDA's QIDP Designation
PJI is a challenging complication of joint arthroplasty with few effective treatment options.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- High-Dose Influenza Vaccination May Benefit Transplant Recipients
- Prehospital Care Lessens Antibiotic Delay in Patients With Sepsis
- Prophylaxis With TMP-SMX Did Not Alter Risk for Non-UTI Infections
- Piperacillin-Tazobactam vs Meropenem for Resistant Bloodstream Infections
- First-Time HIV Testing Low Among Men Who Have Sex With Men
- Antibiotic Prophylaxis Before Dental Procedures May Be Unnecessary
- High-Dose Influenza Vaccination May Benefit Transplant Recipients
- Irritable Bowel Syndrome Treatments
- Oral Ciprofloxacin Effective in Treatment for Bacteremia
- Need for Adequate Screening for Infants With HCV Infected Mothers During Pregnancy
- Supervised Injection Sites: Pros and Cons
- Ledipasvir/Sofosbuvir Effective for Relapsing Hepatitis C Virus GT1
- Higher Loss to Follow-Up After ART Initiation Among Older Adolescents
- New Data Suggests Change in Daptomycin Breakpoint for Enterococcal Bacteremia
- More Socioeconomic Challenges for Hispanic Women With HIV
